MAINE STANDARDS COMPANY, LLC

Maine Standards Company, LLC specializes in the manufacturing of in-vitro diagnostic substances, supporting laboratory operations through the supply of critical reagents and calibration materials. Their technical expertise lies in producing linear reference materials and assay validation supplies used in clinical and research laboratories, ensuring analytical accuracy and regulatory compliance for diagnostic testing workflows. The company’s specialization in on-demand, just-in-time delivery of precision-grade substances enables laboratories to maintain continuity in quality control and method verification processes, particularly in high-throughput or rapidly evolving testing environments. Their focus on reliability and consistency in substance formulation suggests deep familiarity with clinical chemistry standards and laboratory accreditation requirements. The contractor has delivered services to the Department of Health and Human Services, primarily supporting laboratory operations within HHS-affiliated entities such as CDC or NIH research divisions. Their work aligns with public health infrastructure needs, supplying materials essential for diagnostic assay development, proficiency testing, and analytical validation. This relationship indicates a trusted vendor status within federal health research and surveillance networks. The primary industry focus is on NAICS 325413, which encompasses the production of diagnostic reagents, calibrators, and control materials used in clinical laboratories. This places the company at the intersection of biomanufacturing and laboratory diagnostics, serving a niche but vital segment of the in-vitro diagnostics supply chain. Their market positioning is that of a specialized supplier rather than a broad-scale manufacturer, emphasizing precision and responsiveness over volume. Maine Standards Company, LLC operates as a small, likely single-project-focused entity with no publicly disclosed certifications. There is no indication of geographic presence beyond the scope of federal procurement, and no evidence of formal government certifications such as HUBZone, 8(a), or ISO accreditation. Their market footprint is defined by targeted, mission-critical supply contracts rather than broad-scale infrastructure engagement.